Research programme: HIV/AIDS therapeutics - Fox Chase Chemical Diversity Center/ University of Pennsylvania
Latest Information Update: 04 Jul 2016
At a glance
- Originator Fox Chase Chemical Diversity Center; University of Pennsylvania
- Class Small molecules
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical HIV-1 infections
Most Recent Events
- 04 Jul 2016 Preclinical trials in HIV-1 infections in USA (unspecified route)